Ariel Zisman

2.1k total citations · 1 hit paper
14 papers, 1.6k citations indexed

About

Ariel Zisman is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Ariel Zisman has authored 14 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Physiology and 5 papers in Molecular Biology. Recurrent topics in Ariel Zisman's work include Diabetes and associated disorders (5 papers), Adipose Tissue and Metabolism (5 papers) and Diabetes Management and Research (4 papers). Ariel Zisman is often cited by papers focused on Diabetes and associated disorders (5 papers), Adipose Tissue and Metabolism (5 papers) and Diabetes Management and Research (4 papers). Ariel Zisman collaborates with scholars based in United States, Canada and Germany. Ariel Zisman's co-authors include Odile D. Peroni, Barbara B. Kahn, Luz Marina Prieto, Roberto Mejía, Guillermo E. Umpierrez, Dawn Smiley, Andrés Palacio, C. Ronald Kahn, Antti Virkamäki and Franck Mauvais‐Jarvis and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Molecular and Cellular Biology.

In The Last Decade

Ariel Zisman

13 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance

2000 612 citations Ariel Zisman, Odile D. Peroni et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ariel Zisman United States	10	743	732	485	375	358	14	1.6k
Melanie K. Shadoan United States	19	683 0.9×	586 0.8×	225 0.5×	496 1.3×	213 0.6×	27	1.5k
Naohisa Oda Japan	17	504 0.7×	923 1.3×	299 0.6×	973 2.6×	796 2.2×	37	2.1k
Akira Kuroe Japan	19	819 1.1×	497 0.7×	326 0.7×	507 1.4×	157 0.4×	35	1.6k
Kazuaki Miyake Japan	17	304 0.4×	1.0k 1.4×	359 0.7×	514 1.4×	278 0.8×	31	1.6k
Peter A. Antinozzi United States	19	349 0.5×	737 1.0×	358 0.7×	741 2.0×	376 1.1×	23	1.4k
Ond⊘řej Šeda Czechia	21	252 0.3×	519 0.7×	261 0.5×	189 0.5×	261 0.7×	84	1.1k
Søren A. Urhammer Denmark	32	810 1.1×	1.2k 1.6×	930 1.9×	829 2.2×	603 1.7×	50	2.6k
Mia Klannemark Sweden	9	281 0.4×	958 1.3×	688 1.4×	377 1.0×	569 1.6×	11	1.8k
Mandeep Bajaj India	17	543 0.7×	555 0.8×	476 1.0×	270 0.7×	113 0.3×	38	1.4k
Susanne Famulla Germany	11	688 0.9×	294 0.4×	373 0.8×	385 1.0×	179 0.5×	15	1.4k

Countries citing papers authored by Ariel Zisman

Since Specialization

Citations

This map shows the geographic impact of Ariel Zisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel Zisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel Zisman more than expected).

Fields of papers citing papers by Ariel Zisman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel Zisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel Zisman. The network helps show where Ariel Zisman may publish in the future.

Co-authorship network of co-authors of Ariel Zisman

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel Zisman. A scholar is included among the top collaborators of Ariel Zisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel Zisman. Ariel Zisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Siegmund, Thorsten, et al.. (2018). A higher blood glucose level pre-breakfast in comparison to bedtime is a contraindication for intensification of prandial insulin therapy in patients with type 2 diabetes – The impact of a negative BeAM value. Journal of Clinical & Translational Endocrinology. 14. 34–38. 1 indexed citations

2.

Zisman, Ariel, et al.. (2018). Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L. Diabetes Therapy. 9(5). 2155–2162. 5 indexed citations

3.

Zisman, Ariel, et al.. (2016). BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin. BMJ Open Diabetes Research & Care. 4(1). e000171–e000171. 16 indexed citations

4.

Umpierrez, Guillermo E., Dawn Smiley, Ariel Zisman, et al.. (2007). Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial). Diabetes Care. 30(9). 2181–2186. 496 indexed citations

5.

Kitabchi, Abbas E., et al.. (2007). Prediabetes. The Journal of Clinical Endocrinology & Metabolism. 92(1). E1–E1.

6.

Kim, Young‐Bum, Odile D. Peroni, William G. Aschenbach, et al.. (2005). Muscle-Specific Deletion of the Glut4 Glucose Transporter Alters Multiple Regulatory Steps in Glycogen Metabolism. Molecular and Cellular Biology. 25(21). 9713–9723. 51 indexed citations

7.

Zheng, Feng, Flavia Cornacchia, Ivonne Hernandez Schulman, et al.. (2004). Development of Albuminuria and Glomerular Lesions in Normoglycemic B6 Recipients of db/db Mice Bone Marrow. Diabetes. 53(9). 2420–2427. 37 indexed citations

8.

Kulkarni, Rohit & Ariel Zisman. (2003). Lessons for human diabetes from experimental mouse models. Current Diabetes Reports. 3(2). 168–175. 3 indexed citations

9.

Zheng, Feng, Anna Rita Plati, M. Potier, et al.. (2003). Resistance to Glomerulosclerosis in B6 Mice Disappears after Menopause. American Journal Of Pathology. 162(4). 1339–1348. 62 indexed citations

10.

Kim, Jason K., Ariel Zisman, Jonathan J. Fillmore, et al.. (2001). Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. Journal of Clinical Investigation. 108(1). 153–160. 17 indexed citations

11.

Kim, Jason K., Ariel Zisman, Jonathan J. Fillmore, et al.. (2001). Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. Journal of Clinical Investigation. 108(1). 153–160. 157 indexed citations

12.

Zisman, Ariel, Odile D. Peroni, E. Dale Abel, et al.. (2000). Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nature Medicine. 6(8). 924–928. 612 indexed citations breakdown →

13.

Delaney, Miriam F., et al.. (2000). DIABETIC KETOACIDOSIS AND HYPERGLYCEMIC HYPEROSMOLAR NONKETOTIC SYNDROME. Endocrinology and Metabolism Clinics of North America. 29(4). 683–705. 116 indexed citations

14.

Mauvais‐Jarvis, Franck, Antti Virkamäki, Jonathon N. Winnay, et al.. (2000). A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes.. Diabetes. 49(12). 2126–2134. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact